The Food and Drug Administration may approve the Emergency Use Authorization (EUA) application of US drug firm Pfizer for its coronavirus disease 2019 (Covid-19) vaccine before the end of January next year.
“Since we’re working now, I would say before the end of January,” said FDA Director-General Eric Domingo in a television interview when asked about the status of Pfizer’s EUA application.
“The evaluation is going to take about two weeks, so it was given to us right before Christmas. So I’m giving the evaluators up to the first week of January and of course, I have to consolidate the report,” he added.
Domingo said the EUA is a document that is not just made up of letter.
“It’s going to be a big document that will specify all of the conditions for authorization.”
Pfizer submitted its application for EUA to the FDA last December 23. The company already obtained an EUA from the FDA of the United States and United Kingdom for its Covid-19 vaccines. SOVEREIGNPH